Epi-pen shortage hits Canada

An Epi-pen shortage has hit Canada as drug manufacturer Pfizer explains that a manufacturing disruption has impacted production of the lifesaving drug. Epi-pens contain epinephrine, a chemical that narrows blood vessels and opens airways in the lungs. Pfizer and Health Canada said they expect the shortage to last anywhere form a couple to a few weeks.